Published in Am J Med Sci on April 01, 2001
Dual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictions. AAPS J (2007) 1.06
Genetics and mediators in pulmonary arterial hypertension. Clin Chest Med (2007) 1.06
The role of the NO axis and its therapeutic implications in pulmonary arterial hypertension. Heart Fail Rev (2003) 0.93
Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension? BMC Pulm Med (2011) 0.92
Serotonin induces pulmonary artery smooth muscle cell migration. Biochem Pharmacol (2006) 0.90
Comparison of body habitus in patients with pulmonary arterial hypertension enrolled in the Registry to Evaluate Early and Long-term PAH Disease Management with normative values from the National Health and Nutrition Examination Survey. Mayo Clin Proc (2011) 0.89
Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals. BMC Med (2008) 0.87
Obesity and pulmonary hypertension: a review of pathophysiologic mechanisms. J Obes (2012) 0.79
Phobic memory and somatic vulnerabilities in anorexia nervosa: a necessary unity? Ann Gen Psychiatry (2005) 0.75
Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci U S A (1994) 2.28
Direct role for potassium channel inhibition in hypoxic pulmonary vasoconstriction. Am J Physiol (1992) 2.24
A redox-based O2 sensor in rat pulmonary vasculature. Circ Res (1993) 1.83
Differential distribution of electrophysiologically distinct myocytes in conduit and resistance arteries determines their response to nitric oxide and hypoxia. Circ Res (1996) 1.74
Oxygen-induced constriction of rabbit ductus arteriosus occurs via inhibition of a 4-aminopyridine-, voltage-sensitive potassium channel. J Clin Invest (1996) 1.72
O2 sensing is preserved in mice lacking the gp91 phox subunit of NADPH oxidase. Proc Natl Acad Sci U S A (1999) 1.67
A placebo-controlled trial of prostacyclin in acute respiratory failure in COPD. Chest (1996) 1.52
Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factor. Biochem Biophys Res Commun (1989) 1.46
Histamine H1- and H2-receptors in pulmonary and systemic vasculature of the dog. Am J Physiol (1975) 1.40
The genetic factor influencing pulmonary hypertension in cattle at high altitude. Cardiovasc Res (1974) 1.30
Alterations in a redox oxygen sensing mechanism in chronic hypoxia. J Appl Physiol (1985) (2001) 1.19
Redox status in the control of pulmonary vascular tone. Herz (1986) 1.12
Oxygen causes fetal pulmonary vasodilation through activation of a calcium-dependent potassium channel. Proc Natl Acad Sci U S A (1996) 1.11
Hydroxylamine is a vasorelaxant and a possible intermediate in the oxidative conversion of L-arginine to nitric oxide. Biochem Biophys Res Commun (1989) 1.10
Increased endothelium-derived NO in hypertensive pulmonary circulation of chronically hypoxic rats. J Appl Physiol (1985) (1994) 1.10
"Maximal" drug therapy is not necessarily optimal in chronic angina pectoris. J Am Coll Cardiol (1984) 1.09
Potassium channels regulate tone in rat pulmonary veins. Am J Physiol Lung Cell Mol Physiol (2001) 1.09
Purulent pericarditis in children: an analysis of 28 cases. Thorax (1977) 1.09
Coexistent pulmonary and portal hypertension: morphologic and clinical features. J Am Coll Cardiol (1987) 1.07
Molecular identification of O2 sensors and O2-sensitive potassium channels in the pulmonary circulation. Adv Exp Med Biol (2000) 1.06
Endotoxin and prevention of hypoxic pulmonary vasoconstriction. J Lab Clin Med (1976) 1.06
Chronic EDRF inhibition and hypoxia: effects on pulmonary circulation and systemic blood pressure. J Appl Physiol (1985) (1993) 1.05
Opposing effects of oxidants and antioxidants on K+ channel activity and tone in rat vascular tissue. Exp Physiol (1995) 1.02
Simultaneous measurement of O2 radicals and pulmonary vascular reactivity in rat lung. J Appl Physiol (1985) (1989) 1.02
The non specificity of specific nitric oxide synthase inhibitors. Biochem Biophys Res Commun (1992) 1.00
Does normoxic pulmonary vasodilatation rather than hypoxic vasoconstriction account for the pulmonary pressor response to hypoxia? Lancet (1978) 0.99
Potassium channel diversity in vascular smooth muscle cells. Can J Physiol Pharmacol (1997) 0.96
Effect of captopril on uterine blood flow and prostaglandin E synthesis in the pregnant rabbit. J Clin Invest (1983) 0.96
Cardiovascular abnormalities in cutis laxa. Eur J Cardiol (1977) 0.96
Dithionite increases radical formation and decreases vasoconstriction in the lung. Evidence that dithionite does not mimic alveolar hypoxia. Circ Res (1995) 0.94
Enhanced chemiluminescence as a measure of oxygen-derived free radical generation during ischemia and reperfusion. Circ Res (1990) 0.93
Comparison of the hemodynamic effects of nitric oxide and endothelium-dependent vasodilators in intact lungs. J Appl Physiol (1985) (1990) 0.92
Diphenylene iodonium blocks K+ and Ca2+ currents in type I cells isolated from the neonatal rat carotid body. Neurosci Lett (1994) 0.91
Redox control of oxygen sensing in the rabbit ductus arteriosus. J Physiol (2001) 0.89
Prostaglandin synthetase inhibitors do not decrease hypoxic pulmonary vasoconstriction. J Appl Physiol (1976) 0.89
Detection of activated O2 species in vitro and in rat lungs by chemiluminescence. J Appl Physiol (1985) (1989) 0.88
Practical problems in assessing risk for coronary artery bypass grafting. J Thorac Cardiovasc Surg (1985) 0.88
Adenosine and selective reduction of pulmonary vascular resistance in primary pulmonary hypertension. Circulation (1991) 0.87
Failure of histamine antagonists to prevent hypoxic pulmonary vasoconstriction in dogs. J Appl Physiol (1976) 0.87
Platelet-mediated pulmonary hypertension and hypoxia during pulmonary microembolism: reduction by platelet inhibition. Chest (1978) 0.86
Severe aortic incompetence caused by systemic lupus erythematosus. A case report. S Afr Med J (1978) 0.86
Diagnosis of aortic stenosis in older age groups using external carotid pulse recording and phonocardiography. Br Heart J (1981) 0.86
Potentiation of hypoxic pulmonary vasoconstriction by ethyl alcohol in dogs. J Appl Physiol Respir Environ Exerc Physiol (1978) 0.85
Vascular hypertrophy in cattle susceptible to hypoxic pulmonary hypertension. J Appl Physiol Respir Environ Exerc Physiol (1979) 0.84
Oxygen radicals and antioxidant enzymes alter pulmonary vascular reactivity in the rat lung. J Appl Physiol (1985) (1989) 0.84
Pulmonary hypertension in systemic lupus erythematosus: effect of vasodilators on pulmonary hemodynamics. J Rheumatol (1985) 0.84
A maturational shift in pulmonary K+ channels, from Ca2+ sensitive to voltage dependent. Am J Physiol (1998) 0.83
Platelets are not essential for the pulmonary vascular pressor response to hypoxia. J Lab Clin Med (1976) 0.83
Analysis of the complications of cardiac catheterization over nine years. Cathet Cardiovasc Diagn (1982) 0.83
Perioperative risk of complete heart block in patients with bifascicular block and prolonged PR interval. Thorax (1981) 0.83
Postischemic oxygen radical production varies with duration of ischemia. Am J Physiol (1993) 0.82
Ventilation-induced pulmonary vasodilation at birth is modulated by potassium channel activity. Am J Physiol (1996) 0.82
Dexfenfluramine increases pulmonary artery smooth muscle intracellular Ca2+, independent of membrane potential. Am J Physiol (1999) 0.82
Hydrogen peroxide contracts airway smooth muscle: a possible endogenous mechanism. Respir Physiol (1981) 0.81
Pulmonary hypertension and edema induced by platelet-activating factor in isolated, perfused rat lungs are blocked by BN52021. J Lab Clin Med (1988) 0.81
Normal catecholamine and hemodynamic responses to orthostatic tilt in subjects with mitral valve prolapse. Correlation with psychologic testing. Am J Med (1985) 0.81
Effect of dietary fish oil on lung lipid profile and hypoxic pulmonary hypertension. J Appl Physiol (1985) (1989) 0.80
Oxygen-tension-dependent pulmonary vascular responses to vasoactive agents. Can J Physiol Pharmacol (1977) 0.80
The effect of the anorectic agent, d-fenfluramine, and its primary metabolite, d-norfenfluramine, on intact human platelet serotonin uptake and efflux. J Thromb Haemost (2003) 0.80
Superoxide reduction of a disulfide: a model of intracellular redox modulation? Biochem Biophys Res Commun (1994) 0.80
Acute hypoxic pulmonary vasoconstriction: a model of oxygen sensing. Physiol Res (1995) 0.80
The pathobiology of pulmonary hypertension. Smooth muscle cells and ion channels. Clin Chest Med (2001) 0.80
Comparative effects of nifedipine, verapamil, and diltiazem on experimental pulmonary hypertension. Am J Cardiol (1983) 0.80
Platelet antiserum inhibits hypoxic pulmonary vasoconstriction in the dog. J Appl Physiol (1976) 0.79
Myocardial infarction in the black population of South Africa: coronary arteriographic findings. Am Heart J (1978) 0.79
The effects of substance P on the preconstricted pulmonary vasculature of the anesthetized dog. Proc Soc Exp Biol Med (1986) 0.79
Distal airway responses to changes in oxygen and carbon dioxide tensions. Respir Physiol (1979) 0.78
Effects of fluoxetine, phentermine, and venlafaxine on pulmonary arterial pressure and electrophysiology. Am J Physiol (1999) 0.78
Pulmonary microembolism: attenuated pulmonary vasoconstriction with prostaglandin inhibitors and antihistamines. Prostaglandins (1976) 0.78
Prostaglandin E1 inhibits the pulmonary vascular pressor response to hypoxia and prostaglandin F2alpha. Prostaglandins (1975) 0.78
Captopril: association with fetal death and pulmonary vascular changes in the rabbit. Proc Soc Exp Biol Med (1982) 0.78
Pulmonary vascular reactivity. Deckers, Colorado, October 10-12, 1984. Bull Eur Physiopathol Respir (1986) 0.78
High incidence of acute coronary occlusions complicating percutaneous transluminal coronary angioplasty for angina pectoris. Am J Cardiol (1989) 0.78
Inhibition of hypoxic pulmonary vasoconstriction by dipyridamole is not platelet mediated. Can J Physiol Pharmacol (1977) 0.78
Serum creatine kinase isoenzyme MB in acute and chronic alcoholism. Am Heart J (1983) 0.77
Ion channels in the pulmonary vasculature. Pulm Pharmacol Ther (1999) 0.77
Comparative effects of nisoldipine, nifedipine and bepridil on experimental pulmonary hypertension. J Pharmacol Exp Ther (1985) 0.77
Increased pulmonary vascular pressor response to hypoxia in highland dogs. Proc Soc Exp Biol Med (1977) 0.77
Pulmonary vascular effects of endotoxin in leukopenic dogs. Am Rev Respir Dis (1978) 0.77
Superoxide dismutase: master and commander? Eur Respir J (2010) 0.77
Dexfenfluramine elevates systemic blood pressure by inhibiting potassium currents in vascular smooth muscle cells. J Pharmacol Exp Ther (1999) 0.77
Redox status and pulmonary vascular reactivity. Chest (1985) 0.77
Safety and compatibility of betaxolol hydrochloride combined with diltiazem or nifedipine therapy in stable angina pectoris. Am J Cardiol (1994) 0.76
The management of intractable angina pectoris using saphenous vein bypass grafts. Experience in Cape Town. S Afr Med J (1974) 0.76
Diamide inhibits pulmonary vasoconstriction induced by hypoxia or prostaglandin F2 alpha. Proc Soc Exp Biol Med (1983) 0.76
Prostaglandin E1 in infants with pulmonary atresia. S Afr Med J (1978) 0.76
Long term effects of the anorectic agent fenfluramine alone and in combination with aminorex on pulmonary and systemic circulation in the pig. Basic Res Cardiol (1979) 0.76
Fenfluramine: riddle or Rosetta stone? Eur Respir J (2008) 0.76
ZK 36-374, a stable analog of prostacyclin, prevents acute hypoxic pulmonary hypertension in the dog. J Am Coll Cardiol (1986) 0.76
Prostaglandin synthesis does not mediate the pulmonary vasodilatory effect of acetylcholine. Prostaglandins (1976) 0.76
Zymosan activation of plasma reduces hypoxic pulmonary vasoconstriction. Respir Physiol (1983) 0.76
Minoxidil reduces pulmonary vascular resistance in dogs and cattle. J Lab Clin Med (1976) 0.76
Superoxide dismutase: an antireductant enzyme? Biochem Soc Trans (1993) 0.76
Hemodynamic effects of nifedipine at rest and during exercise in primary pulmonary hypertension. Chest (1984) 0.76
Pulmonary vascular tone is increased by a voltage-dependent calcium channel potentiator. J Appl Physiol (1985) (1986) 0.75
Valve replacement for rheumatic aortic incompetence in adolescents. Thorax (1978) 0.75
Non-invasive observations on initial low frequency vibrations of the first heart sound--correlation with the 'presystolic' murmur in mitral stenosis. Br Heart J (1978) 0.75
Effect of normoxia and hypoxia on K(+) current and resting membrane potential of fetal rabbit pulmonary artery smooth muscle. Physiol Res (2005) 0.75
Double outlet right ventricle: clinical and anatomical spectrum. Thorax (1978) 0.75
Hypoxic pulmonary vasoconstriction is unaltered by creatine depletion induced by dietary beta-guanidino propionic acid. Life Sci (1989) 0.75